Orphan drug market to double as Pharma rethinks business model
The global orphan drug market is expected to double between 2016 and 2022 to $209bn as Pharma rethinks its business model away from...
Gottlieb Plans to Streamline the Orphan Drug Review Process
FDA Commissioner Scott Gottlieb, MD, testified before a Senate Appropriations Subcommittee to discuss some of the programs he is...
It's official: New FDA Head Confirmed
The Senate voted 57 to 42 on Tuesday to confirm Dr. Scott Gottlieb as commissioner of the Food and Drug Administration, where he will be...
May is Ichthyosis Awareness Month!
We are so excited to support and promote Ichthyosis Awareness Month (IAM)! For more information and a list of all the amazing ways you...
FDA: Helping Small Businesses Get Big Results
A recently published article by the FDA Voice, the official blog of the FDA, details the impact small businesses are having on the...
Is New York City the next big biotech hub?
Nature Magazine publishes article depicting the recent news of New York City's $1.15 billion biotech investment plan. According to the...
Only 2 weeks left until Rare Disease Day 2017!
February 28th, 2017 marks the 10th international Rare Disease Day. On and around this day hundreds of patient organizations from...
Orphan Drugs in 2016
The FDA Law Blog posted an informative article yesterday sharing insight into the status of the orphan drug landscape last year. In...
President Obama Signs the 21st Century Cures Act
On December 13, 2016, President Obama signed into law the 21st Century Cures Act. Robert Califf, MD, Commissioner of the FDA, stated...
December 2016 Marks Patagonia's 3 Year Anniversary!
December 2016 marks Patagonia's 3 year anniversary! We're very proud of our accomplishments over the past few years and excited to keep...
